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Abstract The effect of a keto-derivative of cholesterol, namely, 6-ketocholestanol(5a-cholestan-3/J-ol-6-one; kCh) on the uncoupling of oxidation 
and phosphorylation by various uncouplers was studied in rat heart mitochondria. kCh was found to completely abolish the uncoupling effect (the 
increase in the respiration rate under the respiratory control conditions and the decrease in the membrane potential) caused of FCCP, CCCP and 
SF6847 and partially by TTFB at low concentrations of uncouplers. It was without effect on the uncoupling by PCP, DNP and palmitate. 
Carboxyatractylate, a specific inhibitor of the ADP/ATP-antiporter, was shown to almost completely abolish the uncoupling induced by palmitate 
and partially by low concentration ofTTFB, PCP and DNP. Effects of high concentrations of all these uncouplers as well as of any concentrations 
of gramicidin proved to be kCh- and carboxyatractilate-insensitive. The data are discussed in terms of the hypothesis on the protein-mediated 
mechanism of the protonophorous uncoupling. 
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1. Introduction 
In bioenergetic studies, protonophorous uncouplers are, 
probably, the most frequently used agents. The great majority 
of uncouplers represent rather hydrophobic weak acids. The 
negative charge of their anionic form is strongly delocalized 
which decreases hydratation and, hence, makes the phospho- 
lipid bilayer permeable to the anionic form of these com- 
pounds. The mechanisms of proton transfer by uncouplers 
were extensively studied in experiments with model phospho- 
lipid membranes (see [l] for review). These studies revealed, in 
particular, the significance of electrical potentials to the effi- 
ciency of proton transfer by various uncouplers [2-4]. 
At least three distinct electrical potentials can be defined in 
lipid bilayers i.e. (i) surface potential, (ii) transmembrane po- 
tential and (iii) so-called dipole potential [S-7]. Although the 
nature of the dipole potential has not been clearly identified 
[8,9], it is believed to be responsible for the observed permeabil- 
ity differences of bilayers to hydrophobic cations and anions 
[3,4,6,10,11]. A number of compounds are known to modify the 
dipole potential. For example, phloretin was shown to reduce 
the magnitude of the dipole potential [7,12,13]. This compound 
was also shown to decrease the uncoupling efficiency of FCCP 
in rat liver mitochondria [14]. Recently, a new agent has been 
introduced, namely 6-ketocholestanol (5a-cholestan-3/l-01-6- 
one; kCh), the cholesterol derivative containing a keto group, 
which increases the membrane dipole potential, thus increasing 
*Corresponding author. Fax: (7) (095) 939 0338. 
Abbreviations: AY, transmembrane electrical potential difference; BSA, 
bovine serum albumin; cAtr, carboxyatractylate; CCCP, carbonylcya- 
nide-3-chlorophenylhydrazone; Ch, cholesterol; DNP, 2,4dinitrophe- 
nol; EGTA, ethylene glycol-bis(&minoethylether)-N,N,N’,N’- 
tetraacetic acid; FCCP, p-tritluoromethoxycarbonylcyanide phenyl- 
hydrazone; kCh, 6-ketocholestanol (Sa-Cholestan-3/I-ol-6-one); 
MOPS, morpholinopropane sulphonate; PMS, phenazine metho- 
sulphate; TPP+, tetraphenyl phosphonium; ‘ITFB, tetrachlorotri- 
fluoromethylbenximidazole. 
the binding and the translocation rate of hydrophobic anions 
[11,15]. 
Here we report the evidence that 6-ketocholestanol abolishes 
the action of the most potent uncouplers on rat heart mitochon- 
dria. 
2. Materials and methods 
Mitochondria were isolated from rat heart muscle. Cooled muscles, 
previously purified from fat and tendons, were minced and passed 
through a stainless teel press with holes about 1 mm in diameter. The 
tissue was then homogenized for 3 min with a Teflon pestle in a glass 
(Pyrex) homogenizer, the tissue :isolation mixture ratio being 1: 8. After 
the first centrifugation (10 min, 600 x g), the supematant was decanted 
and filtered through gauze, then centrifuged (10 min, 12,000 x g). The 
sediment was suspended in 1 ml isolation mixture (250 mM sucrose, 10 
mM MOPS, 1 mM EDTA, pH 7.4) supplemented with BSA (3 mg/ml). 
Then the mixture without BSA was added. The final mitochondrial 
precipitate (10 min, 12,000 x g) was suspended in the isolation medium 
with BSA. The mitochondrial suspension (70-90 mglml) was stored on 
ice. 
In the majority of the experiments, the incubation mixture contained 
250 mM sucrose, 10 mM MOPS, 2 mM KH,P04, BSA (0.2 mg/ml), 
oligomycin (2 &ml) and 0.5 mM EGTA, pH 7.4. Glutamate (5 mM) 
and malate (5 mM) or 5 mM ascorbate and 1 ,uM PMS were used as 
oxidation substrates. In the latter case, the medium contained 2 PM 
rotenone. 
Oxygen consumption was recorded with a Clark-type oxygen elec- 
trode and an LP-7E polarograph. The concentration of mitochondrial 
protein was 0.8-1.2 m&ml. Temperature, 26°C. 
The AY changes were estimated using safranin 0 [l&18]. The differ- 
ence of absorbances at 555 nm and at 523 nm was recorded; the AY 
decrease led to an increasing absorbance difference. The concentration 
of mitochondrial protein was 0.7-0.9 mg/ml. 
Pahnitic acid, FCCP, CCCP, ‘ITFB, SF6847, kCh, rotenone and 
oligomycin were dissolved in twice distilled ethanol. 
Oligomycin, MOPS, pahnitic acid, glutamate, CAtr, CCCP, kCh and 
fatty acid-free BSA were from Sigma; EDTA, EGTA, rotenone, and 
DNP were from Serva; malate was from Calbiochem; FCCP was from 
Boehringer. 
3. Results 
The respiration of rat heart mitochondria oxidizing gluta- 
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Fig. 1. Effects of cAtr and kCh on mitochondrial respiration stimulated 
by various uncouplers. The incubation mixture (see section 2) was 
supplemented with 5 mM glutamate and 5 mM malate. kCh and cAtr 
were added before mitochondria. Additions: 2 PM cAtr, 80 PM kCh. 
mate and malate in the presence of oligomycin was measured 
at various concentrations of uncouplers with or with- 
out 6-ketocholestanol (kCh). Fig. 1A shows that kCh strongly 
inhibits respiration released by adding SF6847, whereas 
carboxyatractylate xerts only a very slight effect. Similar data 
were also obtained with FCCP and CCCP (not shown). When 
mitochondrial respiration is stimulated by TTFB, the effect of 
kCh is small and that of carboxyatractylate is rather strong 
(Fig. 1B). The increase in the respiration rate induced by DNP 
or by pahnitate is, in fact, insensitive to kCh (Fig. 1C) but 
inhibited by carboxyatractylate, the inhibition being especially 
strong with pahnitate (not shown). 
Fig. 2A shows that kCh completely restores the membrane 
potential of rat heart mitochondria strongly lowered by 8 nM 
SF6847, while the addition of cholesterol is without effect. On 
the other hand, kCh is ineffective when the membrane potential 
is lowered by PCP. In this case carboxyatractylate partially 
restores the potential (Fig. 2B). 
The effect of different concentrations of kCh on the mem- 
brane potential decrease induced by SF6847, FCCP and TIFB 
is shown in Fig. 3A-C. It is seen that kCh is equally efficient 
in completely abolishing the A!? decrease induced by low con- 
centrations of FCCP and SF6847 (Fig. 3A and B) whereas it 
has only a slight effect on that induced by TI’FB (Fig. 3C). kCh 
fails to abolish the effect of high concentrations of SF6847, 
FCCP and TIFB (Fig. 3) and of any concentrations of PCP, 
DNP, palmitate and gramicidin (not shown). 
4. Discussi 
It is known that 6-ketocholestanol (kCh) increases both the 
translocation rate and the binding of hydrophobic anions in the 
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Fig. 2. Dynamics of the mitochondrial membrane potential (LW) meas- 
ured with safranin 0: effects of uncouplers, kCh and cAtr. The incuba- 
tion mixture (see section 2) was supplemented with 7 PM safranin 0; 
5 mM ascorbate and 1 PM PMS were used as oxidation substrates. 
Mito, rat heart mitochondria (0.7 mg/mf). 
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Fig. 3. Effects of different concentrations of 6-ketocholestanol n the 
uncoupler-induced AY decrease in rat heart mitochondria. The ampli- 
tude of the absorption changes from the initial maximal level (after 
addition of mitochondria) to the final lowest level (when the oxygen in 
the incubation cuvette was exhausted) were taken as 100%. When pres- 
ent, kCh was added to incubation media before the addition of mito- 
chondria. The incubation mixture was as in Fig. 2. 
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phosphatidylcholine liposomes [l 11. Recently we have repro- 
duced these data on planar bilayer phospholipid membranes 
composed of azolectin. In this system, kCh stimulates the effect 
of FCCP as a protonophore. We expected this compound to 
potentiate the uncoupling effect of protonophores in mitochon- 
dria. Instead, kCh was shown to abolish uncoupling by low 
concentrations of the most potent protonophores, i.e. SF6847, 
FCCP and CCCP. 
It should be noted that kCh inhibits the action of uncouplers 
which were shown to cross the model phospholipid membrane 
in the form of the anion, A- (FCCP, CCCP, SF6847), rather 
than of the dimer of anionic and protonated species, HA; 
(TTFB, DNP, PCP). Interestingly, the uncoupling effects of 
TTFB, PCP and DNP were partially released by carboxyatrac- 
tylate (the specific inhibitor of the ADP/ATP-antiporter) which 
almost completely abolished uncoupling by low concentrations 
of pahnitate. 
The effect of carboxyatractylate on the pahuitate uncou- 
pling, discovered in this group on mitochondria [19-231, has 
recently been confirmed by Brustovetsky and Klingenberg on 
proteoliposomes inlaid with the ATP/ADP-antiporter [24]. One 
may suggest that there are other, supposedly anion-translo- 
eating protein(s), mediating the carboxyatractylate-resistant ac-
tion of SF6847, FCCP and CCCP. The effects of kCh can be 
explained assuming that it may somehow hinder the access of 
the uncoupler anions to their binding site on these protein(s). 
It should be stressed, however, that the carboxyatractylate- 
or kCh-sensitive uncoupling is inherent in the action of low 
concentrations of uncouplers. At high concentrations, both in- 
hibitors fail to abolish the uncoupling effect which is apparently 
directed at the phospholipid, rather than the protein, constitu- 
ent of the mitochondrial membrane, as was originally proposed 
by Mitchell [25] and demonstrated in our [26] and Lehninger’s 
[271 groups. In agreement with the above concept, the action 
of the channel-forming uncoupler, gramicidin, proved to be 
resistant to kCh as well as carboxyatractylate. 
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